Clinical data | |
---|---|
Trade names | Myagen, Methosarb |
Other names | U-19763; NSC-66233; 7α,17α-Dimethyltestosterone; 7α,17α-Dimethylandrost-4-en-17β-ol-3-one |
Routes of administration | By mouth |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.015.018 |
Chemical and physical data | |
Formula | C21H32O2 |
Molar mass | 316.485 g·mol−1 |
3D model (JSmol) | |
| |
|
Bolasterone (INN , USAN ) (brand names Myagen, Methosarb; former developmental code name U-19763), also known as 7α,17α-dimethyltestosterone, is a 17α-alkylated androgen/anabolic steroid (AAS) which is used in veterinary medicine.[2][3] It has close structural similarity to testosterone, and like methyltestosterone has a methyl group at C17α in order to increase oral bioavailability.[2] In addition, it is also 7α-methylated, similar to its 7β-methylated isomer calusterone.[2] The medication has a low to moderate ratio of anabolic to androgenic activity, similar to that of fluoxymesterone.[4]
Bolasterone is on the World Anti-Doping Agency's list of prohibited substances,[5] and is therefore banned from use in most major sports.